Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Avant's cholera vaccine to enter phase IIb trial

Jan. 19, 2000

Isolation of unnamed tick-borne bacterium causing HGE patented by Aquila

Jan. 17, 2000

FDA accepts NDA for new Rapamune formulation

Jan. 14, 2000

KF-20444 has potent immunosuppressive activity

Jan. 14, 2000

Licensing opportunity from NIH: live attenuated RSV and PIV for use as human vaccines

Jan. 10, 2000

Medarex antibody therapy reduces inflammation in vivo

Jan. 6, 2000

Agents for immune or inflammatory disorders from Boehringer Ingelheim

Jan. 4, 2000

Chiron prepares highly immunogenic and bactericidal N. meningitidis vaccine

Jan. 4, 2000

Preliminary results reported for Biojector 2000-delivered malaria vaccine

Dec. 29, 1999

Japanese patent covers BioSante's novel vaccine adjuvant/drug delivery system

Dec. 28, 1999

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...